Work

Psychopharmacological treatment of avoidant personality disorder

Year: 1989

Type: article

Abstract: Avoidant personality disorder is quite prevalent and can result in marked impairment in social and occupational functioning. Since it has been conceptualized as a disorder of personality, only limited studies of its potential sensitivity to pharmacological treatments have been reported, usually in relation to the treatment of social phobia. This report examines the relationship of avoidant personality disorder to social phobia and describes the successful pharmacotherapy of several patients whose targeted outcomes were their avoidant traits. Our experience with resolution of avoidant features with treatment with monoamine oxidase inhibitors or fluoxitene recommends a 2- to 3-month trial of these agents in patients with avoidant personality disorder whether or not there is comorbidity for another DSM-III-R axis I disorder.

Source: Comprehensive Psychiatry

DOI: 10.1016/0010-440x(89)90079-5

Authors: Joseph A. Deltito, Madeleine Stam

Institution: Cornell University

Language: English

Topic: Personality Disorders and Psychopathology

Subfield: Clinical Psychology

Field: Psychology

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,470